Effects of proprotein convertase subtilisin/kexin type 9 and nilotinib plasma concentrations on nilotinib‐induced hypercholesterolaemia in patients with chronic myeloid leukaemia-Reference-Cited by-同舟云学术

Effects of proprotein convertase subtilisin/kexin type 9 and nilotinib plasma concentrations on nilotinib‐induced hypercholesterolaemia in patients with chronic myeloid leukaemia

Published:2020-10-27 Issue:2 Volume:46 Page:382-387
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Abumiya Maiko¹,Akamine Yumiko¹^ORCID,Sato Shiori¹,Takahashi Saori²³,Yoshioka Tomoko²,Kameoka Yoshihiro²³,Takahashi Naoto²^ORCID,Miura Masatomo¹^ORCID

Affiliation:

1. Department of Pharmacy Akita University Hospital Akita Japan

2. Department of Hematology, Nephrology, and Rheumatology Akita University Graduate School of Medicine Akita Japan

3. Clinical Research Promotion and Support Center Akita University Hospital Akita Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13294

Reference25 articles.

1. Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib

2. Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

3. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

4. Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia

5. Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Nilotinib With Cardiovascular Diseases in Patients With Chronic Myelogenous Leukemia: A National Population-Based Cohort Study;The Oncologist;2023-08-10

2. Concentration of low-density lipoproteins (LDL) is significantly reduced after nilotinib discontinuation;Scientific Reports;2023-07-21

3. Haematological Drugs Affecting Lipid Metabolism and Vascular Health;Biomedicines;2022-08-10

4. Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia;Cells;2022-01-18